Alex Goldberg

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and PetSmart, Inc. (NASDAQ:PETM) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/24/2014 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and PetSmart, Inc. (NASDAQ:PETM).

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) a development stage pharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceutical products closed up in its previous session (+1.51%) on 5,492,012 shares traded after CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Filed SEC form 8-K, Other Events, Financial Statements and Exhibits. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) is currently up (+301.32%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)

PetSmart, Inc. (NASDAQ:PETM) a company that together with its subsidiaries, operates as a specialty retailer of products, services, and solutions for pets in the United States, Puerto Rico, and Canada closed up in its previous session (+0.08%) on 1,749,623 shares traded. PetSmart, Inc. (NASDAQ:PETM) is currently up (+6%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about PetSmart, Inc. (NASDAQ:PETM)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com